BU virologist Nancy Sullivan says the Bundibugyo outbreak within the Democratic Republic of the Congo underscores the necessity for broader outbreak preparedness.
The demise of a nurse marked the second well being officers acknowledged that one thing harmful was spreading. The sickness was Bundibugyo virus, a uncommon however doubtlessly lethal an infection now driving a rising outbreak within the Democratic Republic of Congo and exposing how poorly ready well being techniques may be for ailments that obtain little consideration between emergencies.
Boston College professor Nancy Sullivan examines that vulnerability in a overview printed within the New England Journal of Medication. She argues that the outbreak ought to function a warning: planning can’t focus solely on the infectious threats almost certainly to make headlines.
Bundibugyo belongs to the filovirus household, a gaggle of viruses that features the better-known Ebola virus. Earlier than the present disaster, well being officers had acknowledged solely two Bundibugyo outbreaks—in Uganda in 2007 and the Democratic Republic of Congo (DRC) in 2012—however the newest outbreak has already surpassed each in its tempo and dimension. In line with the WHO, 695 instances and 138 deaths had been confirmed within the DRC and Uganda as of June 11.
Delays weaken outbreak management
Stopping a virus like Bundibugyo relies on pace. Sullivan, a Boston College professor of biology and virology, immunology & microbiology, explains that well being employees should shortly determine infections, separate sufferers from others, hint individuals who might have been uncovered, strengthen infection-control measures, and supply supportive care.
Every step helps break a unique hyperlink within the chain of transmission. But in locations with restricted laboratory sources, even figuring out what illness a affected person has can take too lengthy. Testing delays can go away contaminated folks involved with relations, caregivers, and different sufferers whereas the virus continues spreading.
Bundibugyo causes extreme hemorrhagic fever, an sickness that may set off widespread irritation, injury the inside lining of blood vessels, produce uncontrolled bleeding, and result in the failure of a number of organs. The virus passes via direct contact with contaminated bodily fluids, inserting caregivers at specific threat, particularly inside hospitals. The 2026 outbreak was formally recognized after a nurse died.
Prognosis presents one of many best obstacles. Early signs can look very like malaria, typhoid fever and several other different sicknesses, so docs can’t reliably determine Bundibugyo from signs alone. Laboratory affirmation is crucial, Sullivan mentioned.
That requirement creates a logistical drawback within the DRC. Restricted native testing capability means samples might must journey appreciable distances to nationwide reference laboratories, the centralized amenities geared up to substantiate troublesome or harmful infections.
“Delays in specimen assortment, transportation and testing can postpone affirmation by days or perhaps weeks, which hinders the isolation of contaminated individuals, contact tracing and the initiation of outbreak-control measures,” Sullivan wrote.
Uncommon pathogens expose preparedness gaps
The outbreak reveals a broader weak spot in infectious illness planning. Preparedness packages typically focus sources on pathogens thought of the most typical or almost certainly to trigger a serious emergency. Bundibugyo reveals why that technique can go away harmful blind spots.
After many years with little acknowledged exercise, the virus has returned as a severe risk. Its reappearance illustrates how troublesome it’s to foretell which pathogen will drive the subsequent outbreak. Sullivan has referred to as for countermeasures that may handle any virus able to inflicting extreme sickness or demise in people, reasonably than ready till a uncared for illness begins spreading extensively.
Researchers have made progress on vaccines and coverings for the Ebola, Sudan, and Marburg viruses. Bundibugyo happens far much less typically, nonetheless, and no licensed vaccine or remedy has been developed particularly for it. Proof signifies that vaccines designed for different virus species might supply some safety, however that chance doesn’t exchange the necessity for devoted preparation.
“Preparedness planning ought to lengthen past diagnostics, vaccines, and therapeutics to incorporate operational readiness for multinational outbreak response,” she mentioned.
Reference: “Bundibugyo Virus Illness in 2026 — Medical and Public Well being Responses” by Nancy J. Sullivan, 23 June 2026, New England Journal of Medication.
DOI: 10.1056/NEJMra2607216
